Assess Safety and Efficacy of VAD044 in HHT Patients
Status:
Not yet recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this Phase 1b proof of concept study, randomised, placebo controlled, double
blind, multicentre study is to asssess safety and efficacy of 2 doses of VAD044 in adult HHT
patients